Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Antiviral Res. 2020 Feb 17;176:104749. doi: 10.1016/j.antiviral.2020.104749

Figure 1: Inhibitory effect of anisomycin against DENV and ZIKV multiplication in Vero cells.

Figure 1:

Vero cells were infected with (A) DENV-1 (Hawaii), DENV-2 (NGC), DENV-3 (H87) or DENV-4 (8124) (MOI = 1), (B) ZIKV (strains DAK-AR-41524 or PRVABC59) or ZIKV clinical isolate (INEVH116141) (MOI = 1), (C) DENV-2 (NGC) at different MOIs and (D) DENV-2 clinical isolates (MOI=1). After 1h adsorption at 37°C, cells were incubated in MM containing different concentrations of anisomycin. At 48 h p.i. extracellular virus yield was quantified by plaque assay. Data are mean values from three independent experiments ± standard deviation (SD).